BI-655064 is a humanized anti-CD40 antibody with two mutations in its crystallizable fragment (Fc) region, which prevent Fc-mediated antibody-dependent or complement-mediated cytotoxicity and platelet activation. It is utilized in the study of autoimmune diseases, including lupus nephritis and rheumatoid arthritis (RA).